ReviewEClinicalMedicine2025
Measurable residual disease in hematologic malignancies: a biomarker in search of a standard.
Namrata S Chandhok et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
16 papers cite it
this paperpooled itcites it